Inbunden, Engelska, 2024
Del i serien Chapman & Hall/CRC Biostatistics Series
Development of Gene Therapies
Strategic, Scientific, Regulatory, and Access Considerations
Av Avery McIntosh, Oleksandr Sverdlov
3679 kr
Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
Beskrivning
Produktinformation
- Utgivningsdatum: 2024-05-23
- Mått: 178 x 254 x 31 mm
- Vikt: 1 070 g
- Format: Inbunden
- Språk: Engelska
- Serie: Chapman & Hall/CRC Biostatistics Series
- Antal sidor: 458
- Förlag: Taylor & Francis Ltd
- ISBN: 9781032136554
Utforska kategorier
Mer information
Avery McIntosh, Ph.D. is a drug developer working in rare diseases at Pfizer. He received his M.Sc. and Ph.D. in biostatistics from Boston University with a dissertation on Bayesian methods to model household tuberculosis transmission. He has managed teams of statisticians across study phases and in a variety of drug types and disease areas, including neurology, ophthalmology, infectious disease/ global health, hematology, and oncology. He has published peer-reviewed articles on various topics in drug development and biostatistics, including development of cell and gene therapies and qualification of digital endpoints in neurological diseases.Oleksandr Sverdlov, Ph.D. is a Neuroscience Disease Area Statistical Lead at Novartis. He received B.Sc. in Applied Mathematics from V.N. Karazin Kharkiv National University, Ukraine, M.Sc. in Statistics from University of Maryland, Baltimore County (UMBC), and Ph.D. in Information Technology with Concentration in Statistical Science from George Mason University. He has been actively involved in methodological research and applications of innovative statistical approaches in drug development. He has co-authored over forty refereed articles, edited two monographs, and co-authored a book Mathematical and Statistical Skills in the Biopharmaceutical Industry: A Pragmatic Approach (CRC Press/Chapman & Hall, 2019). His most recent work involves design and analysis of clinical trials evaluating novel digital technologies
Recensioner i media
"Development of Gene Therapies excels in demystifying intricate gene therapy and delineating its unique challenges and opportunities. I recommend it without reservation and believe drug developers will immensely benefit from this book. It should be on the bookshelf of any researcher and drug developer interested in gene therapy."-Ying Yuan, Development of gene therapies: strategic, scientific, regulatory, and access considerations by Avery McIntosh and Oleksandr Sverdlov, Chapman and Hall/CRC, 2024, ISBN: 9781032136554, Biometrics, 2025
Butikslager
Ej i lager i butik.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.